1. Home
  2. UTZ vs PCRX Comparison

UTZ vs PCRX Comparison

Compare UTZ & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utz Brands Inc

UTZ

Utz Brands Inc

N/A

Current Price

$8.25

Market Cap

912.7M

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$22.21

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTZ
PCRX
Founded
2018
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
912.7M
1.0B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
UTZ
PCRX
Price
$8.25
$22.21
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$13.00
$35.33
AVG Volume (30 Days)
1.8M
761.1K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
107.44
EPS
0.01
0.16
Revenue
$1,438,800,000.00
$541,533,000.00
Revenue This Year
$4.95
$9.77
Revenue Next Year
$1.59
$9.71
P/E Ratio
$857.50
$137.50
Revenue Growth
2.09
26.04
52 Week Low
$8.37
$18.80
52 Week High
$14.67
$27.99

Technical Indicators

Market Signals
Indicator
UTZ
PCRX
Relative Strength Index (RSI) 29.25 49.39
Support Level N/A $20.41
Resistance Level $10.74 $23.82
Average True Range (ATR) 0.30 0.97
MACD -0.10 -0.02
Stochastic Oscillator 7.64 50.80

Price Performance

Historical Comparison
UTZ
PCRX

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: